Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell deathTrinayan Kashyap, Yosef Landesman|Oncotarget|2016Cited by 129
Selinexor synergizes with dexamethasone to repress mTORC1 signaling and induce multiple myeloma cell deathChristian Argueta, Yosef Landesman|Oncotarget|2018Cited by 45
Preliminary Evidence Of Anti Tumor Activity Of Selinexor (KPT-330) In a Phase I Trial Ofa First-In-Class Oral Selective Inhibitor Of Nuclear Export (SINE) In Patients (pts) With Relapsed / Refractory Non Hodgkin’s Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)John Kuruvilla, Mansoor Raza Mirza, Bijal Shah et al.|Blood|2013Cited by 30